ErlySign Awards & Recognition – Leading Oral Cancer Innovations

Global Recognition, National Impact

ErlySign’s early detection technology is gaining the world’s attention and saving lives where it matters most.

GHP Biotechnology awards 2022

ErlySign was honored with the GHP Biotechnology Award for redefining diagnostic innovation through its saliva-based early cancer detection technology. This recognition reflects our commitment to making life-saving screening accessible and non-invasive.

HealthTech Breakthrough Award 2024

ErlySign proudly received the HealthTech Breakthrough Award for 2024, celebrated as a revolutionary step forward in non-invasive cancer diagnostics. This award validates our tech’s role in reshaping the future of early detection.

Winner of WISHQatar2022 SPARK early stage startups

Chosen among top global health startups at WISHQatar’s SPARK competition, ErlySign stood out for its scalable, life-saving diagnostic solution. The recognition reinforces our potential to create global impact through accessible tech.

10th Edition Global Nagpur Awards

ErlySign received the Global Nagpur Award for innovation in health technology, recognizing our role in bringing world-class cancer detection tools to India’s heartland. This honor celebrates our drive to make early detection the norm.

Featured In

ErlySign has been showcased by top healthcare publications, research institutions, and media outlets for its groundbreaking innovations in detection